The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients-Reference-Cited by-同舟云学术

The Need to Develop Clinical Guidance for the Use of High-Sensitivity Cardiac Troponin in Pediatric and Neonatal Patients

Published:2022-06-15 Issue:7 Volume:68 Page:884-886
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Wang Alan¹,Sandoval Yader²,Apple Fred S³,Homme James⁴,Jaffe Allan S²⁵,Apple Fred S.,Jaffe Allan S.,Ordoñez-Llanos Jorge,Collinson Paul O.,Body Richard,Saenger Amy K.,Kavsak Peter A.,Omland Torbjørn,Aakre Kristin Moberg,Hammarsten Ola,

Affiliation:

1. Division of Pediatric Cardiology, Ann & Robert H. Lurie Children’s Hospital of Chicago , Chicago, IL , USA

2. Department of Cardiovascular Medicine, Mayo Clinic , Rochester, MN , USA

3. Departments of Laboratory Medicine and Pathology, Hennepin Healthcare/Hennepin, County Medical Center and University of Minnesota , Minneapolis, MN , USA

4. Department of Emergency Medicine, Mayo Clinic , Rochester, MN , USA

5. Department of Laboratory Medicine and Pathology, Mayo Clinic , Rochester, MN

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Link

https://academic.oup.com/clinchem/article-pdf/68/7/884/44385897/hvac072.pdf

Reference13 articles.

1. High-sensitivity troponin T testing for pediatric patients in the emergency department;Wang;Pediatr Cardiol,2022

2. Biomarkers and degree of atherosclerosis are independently associated with incident atherosclerotic cardiovascular disease in a primary prevention cohort: The ARIC study;Agarwala;Atherosclerosis,2016

3. Biomarker-based risk model to predict cardiovascular mortality in patients with stable coronary disease;Lindholm;J Am Coll Cardiol,2017